Literature DB >> 1590674

Use of immune modulators in nonspecific therapy of bacterial infections.

M T Vogels1, J W van der Meer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1590674      PMCID： PMC189216          DOI： 10.1128/AAC.36.1.1

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  68 in total

Review 1.  Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. In vitro, in animal models, and in humans.

Authors:  H W Murray
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Sep-Oct       Impact factor: 2.803

2.  Treatment of mice with human recombinant interleukin-2 augments resistance to the facultative intracellular pathogen Listeria monocytogenes.

Authors:  M Haak-Frendscho; K M Young; C J Czuprynski
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

3.  Enhancement of antibacterial resistance of neutropenic, bone marrow-suppressed mice by interleukin-1 alpha.

Authors:  K W McIntyre; J Unowsky; W DeLorenzo; W Benjamin
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

4.  The role of iron in nonspecific resistance to infection induced by endotoxin.

Authors:  R J Elin; S M Wolff
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

Review 5.  Effects of endotoxins on susceptibility to infections.

Authors:  L E Cluff
Journal:  J Infect Dis       Date:  1970-09       Impact factor: 5.226

6.  Antibacterial activity of recombinant murine beta interferon.

Authors:  T Fujiki; A Tanaka
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

7.  Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha.

Authors:  A Minami; K Fujimoto; Y Ozaki; S Nakamura
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

8.  Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1.

Authors:  J W Van't Wout; J W Van der Meer; M Barza; C A Dinarello
Journal:  Eur J Immunol       Date:  1988-07       Impact factor: 5.532

Review 9.  Biology of interleukin 1.

Authors:  C A Dinarello
Journal:  FASEB J       Date:  1988-02       Impact factor: 5.191

10.  Effects of cellular constituents of mycobacteria on the resistance of mice to heterologous infections I. Protective effects.

Authors:  R J DUBOS; R W SCHAEDLER
Journal:  J Exp Med       Date:  1957-11-01       Impact factor: 14.307
View more
  11 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

3.  Noncapsulated Klebsiella pneumoniae bearing mannose-containing O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein D.

Authors:  Elena Kostina; Itzhak Ofek; Erika Crouch; Rotem Friedman; Lea Sirota; Gil Klinger; Hany Sahly; Yona Keisari
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Antibiotic penetration into lung tissues.

Authors:  D Honeybourne
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

Review 5.  Trends in immunotherapy of fungal infections.

Authors:  B J Kullberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

6.  Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.

Authors:  T Lazard; C Perronne; Y Cohen; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines.

Authors:  S Baqar; N D Pacheco; F M Rollwagen
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice.

Authors:  M T Vogels; C C Hermsen; H L Huys; W M Eling; J W van der Meer
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Role of acute-phase proteins in interleukin-1-induced nonspecific resistance to bacterial infections in mice.

Authors:  M T Vogels; L Cantoni; M Carelli; M Sironi; P Ghezzi; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

10.  Interleukin-1-induced nonspecific resistance to bacterial infection in mice is not mediated by glucocorticosteroids.

Authors:  M T Vogels; C G Sweep; A R Hermus; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.